Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies

Abstract The receptor tyrosine kinase ROR1 has been shown to be overexpressed in chronic lymphocytic leukemia (CLL). The aim of this study was to further characterize the expression of ROR1 and the other member of the ROR family, ROR2, in other lymphoid and myeloid malignancies. Normal white blood cells and reactive lymph nodes were negative for ROR1 and ROR2. A significantly high and uniform surface expression of ROR1 was found in CLL/hairy cell leukemia (HCL) compared to mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), myelomas, acute lymphoblastic leukemia (ALL) and myeloid leukemias (p = 0.02 to < 0.001). The lowest proportion of ROR1+ cells was seen in FL, whereas CLL, HCL and CML had significantly higher numbers of ROR1+ cells. Longitudinal follow-up of individual patients with CLL revealed that ROR1+ cells remained stable over time in non-progressive patients, but increased when the disease progressed (p < 0.05). Thus, a variable staining pattern of ROR1 ranging from very high (CLL, HCL) and high (CML) to intermediate (myeloma and DLBCL) or low (FL) was noted. ROR2 was not detected in hematological malignancies.

[1]  Y. Minami,et al.  Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex , 2012, Journal of Cell Science.

[2]  Tomoya Yamaguchi,et al.  NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. , 2012, Cancer cell.

[3]  J. Wang-Rodriguez,et al.  ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth , 2012, PloS one.

[4]  M. Jeddi-Tehrani,et al.  Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells , 2012, Leukemia.

[5]  A. Österborg,et al.  ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) - a Survival Factor for CLL Cells , 2011 .

[6]  G. Widhopf,et al.  ROR1 Expression Accelerates Leukemia Development in RORxTCL1 Transgenic Mice , 2011 .

[7]  L. Rassenti,et al.  ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia. , 2011, Leukemia research.

[8]  M. Hallek,et al.  Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL). , 2011, Leukemia research.

[9]  K. Kwong,et al.  Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies , 2011, PloS one.

[10]  L. Trusolino,et al.  ROR1 is a pseudokinase that is crucial for MET-driven tumorigenesis , 2011, BMC Proceedings.

[11]  L. Reiniger,et al.  ROR1 expression is not a unique marker of CLL , 2011, Hematological oncology.

[12]  Thomas M. Schmitt,et al.  The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. , 2010, Blood.

[13]  A. Basiri,et al.  Expression of ROR1 in patients with renal cancer--a potential diagnostic marker. , 2010, Iranian biomedical journal.

[14]  P. Kokhaei,et al.  Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells , 2010, British journal of haematology.

[15]  Z. Estrov,et al.  Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells , 2010, PloS one.

[16]  N. Oue,et al.  Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase , 2010, Oncogene.

[17]  Yusuke Nakamura,et al.  Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer. , 2009, Carcinogenesis.

[18]  Arnell Carter,et al.  The Orphan Tyrosine Kinase Receptor, ROR2, Mediates Wnt5A Signaling in Metastatic Melanoma , 2009, Oncogene.

[19]  Yusuke Nakamura,et al.  Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma , 2009, Cancer science.

[20]  Y. Minami,et al.  Ror‐family receptor tyrosine kinases in noncanonical Wnt signaling: Their implications in developmental morphogenesis and human diseases , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[21]  E. Wallen,et al.  Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma , 2009, Oncogene.

[22]  P. Sternberg,et al.  Ror receptor tyrosine kinases: orphans no more. , 2008, Trends in cell biology.

[23]  C. Larsson,et al.  Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy , 2008, International journal of cancer.

[24]  L. Rassenti,et al.  Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a , 2008, Proceedings of the National Academy of Sciences.

[25]  Adrian Wiestner,et al.  Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia , 2008, Clinical Cancer Research.

[26]  Jeffrey P. MacKeigan,et al.  Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance , 2005, Nature Cell Biology.

[27]  E. Elonen,et al.  Tumours of haematopoietic and lymphoid tissues: general guidelines , 2004 .

[28]  J. Reilly.  Receptor tyrosine kinases in normal and malignant haematopoiesis. , 2003, Blood reviews.

[29]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[30]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[31]  S. Ashton,et al.  Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development , 2001, Development Genes and Evolution.

[32]  D. Robinson,et al.  The protein tyrosine kinase family of the human genome , 2000, Oncogene.

[33]  G. Yancopoulos,et al.  Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development , 2000, Nature Genetics.

[34]  S. Akira,et al.  Spatio‐temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous system , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[35]  P. Masiakowski,et al.  A novel family of cell surface receptors with tyrosine kinase-like domain. , 1992, The Journal of biological chemistry.

[36]  小林 正樹.  Ror2 expression in squamous cell carcinoma and epithelial dysplasia of the oral cavity , 2008 .

[37]  W. Forrester.  The Ror receptor tyrosine kinase family , 2002, Cellular and Molecular Life Sciences CMLS.